Voltar
Artigo Revisado por pares
BIBTEX RIS

Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

2011; Springer Science+Business Media; Volume: 13; Issue: 3 Linguagem: Inglês

10.1007/s12094-011-0637-6

ISSN

1699-3055

Autores

Cristina Grávalos, Carlos Gómez-Martín, Fernando Rivera, Inmaculada Alés, Bernardo Queralt, Antonia Márquez, Ulpiano Jiménez, Vicente Alonso, Rocio García‐Carbonero, Javier Sastre, Rámón Colomer, H. Cortés-Funes, Antonio Jimeno,

Tópico(s)

Peptidase Inhibition and Analysis

Referência(s)